Barclays Maintains Equal-Weight on Coterra Energy, Raises Price Target to $30

Barclays analyst Jeanine Wai maintains Coterra Energy (NYSE:CTRA) with a Equal-Weight and raises the price target from $26 to $30.

Barclays analyst Jeanine Wai maintains Coterra Energy (NYSE:CTRA) with a Equal-Weight and raises the price target from $26 to $30.

Total
0
Shares
Related Posts
Read More

Amicus Therapeutics Reports Preliminary 2023 Revenue And Provides 2024 Strategic Outlook; Q4 Revenue ~$115.1M Vs $112.25M Est.; Sees FY23 Revenue Of ~$399.4M Vs $396.45M Est.; Co Sees FY24 As First Full Year Of Achieving Non-GAAP Profitability

Bradley Campbell, President and Chief Executive Officer of Amicus Therapeutics, Inc., stated, "Last year was an incredible year for Amicus highlighted by the continued double-digit growth of Galafold sales and the global

FOLD